Search Results Search Sort by RelevanceMost Recent Case and Commentary Apr 2019 Should a Psychiatrist Prescribe a Nanodrug to Help Parents Monitor a Teen’s Adherence? Constance E. George, MD, MA Ethical stakes include a psychiatrist’s care management responsibilities and burdens borne by family members over the course of the patient’s care. AMA J Ethics. 2019;21(4):E317-323. doi: 10.1001/amajethics.2019.317. Medicine and Society May 2019 How Should Mechanical Circulatory Support Be Deactivated for Patients With Depression at the End of Life? Stephan R. Weinland, PhD, MS and James Levenson, MD End-stage heart failure patients can experience depression along with their chronic illness. Multidisciplinary responses are critical. AMA J Ethics. 2019;21(5):E429-434. doi: 10.1001/amajethics.2019.429. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Policy Forum Nov 2019 Why Quality-of-Life Data Collection and Use Should Be Standardized When Evaluating Candidates for Hand Transplantation Martin Kumnig, PhD, MSc, Emma K. Massey, PhD, and Lisa S. Parker, PhD Improving candidate evaluation and informed consent is key to motivating authenticity, not just voluntariness. AMA J Ethics. 2019;21(11):E974-979. doi: 10.1001/amajethics.2019.974. Case and Commentary Sep 2017 What Does Health Justice Look Like for People Returning from Incarceration? Lisa Puglisi, MD, Joseph P. Calderon, CHW, and Emily A. Wang, MD, MAS Equitable transitions of care for incarcerated patients returning to the community will require physician advocacy and systems-level change. AMA J Ethics. 2017;19(9):903-910. doi: 10.1001/journalofethics.2017.19.9.ecas4-1709. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Policy Forum Jul 2019 How Should Unaccompanied Minors in Immigration Detention Be Protected From Coercive Medical Practices? Giselle Malina Safeguards are urgently needed for assessments of what constitutes appropriate care for unaccompanied minors in US detention facilities. AMA J Ethics. 2019;21(7):E603-610. doi: 10.1001/amajethics.2019.603. Health Law Jul 2019 Regional Unrepresented Patient Advocacy Committee as an Alternative for Decision Making Lisa K. Anderson-Shaw, DrPH, MA, MSN, ANP-BC A UPAC is an alternative to engaging a guardianship court appointment process or to using physicians or ethics committees as decision makers. AMA J Ethics. 2019;21(7):E594-599. doi: 10.1001/amajethics.2019.594. Medicine and Society Jul 2019 Who Are “Unrepresented” Patients and What Count as “Important” Medical Decisions for Them? David Ozar, PhD A look at current literature and work by a statewide initiative can motivate development of policies that help respond to unrepresented patients’ needs. AMA J Ethics. 2019;21(7):E611-616. doi: 10.1001/amajethics.2019.611. AMA Code Says Aug 2019 AMA Code of Medical Ethics’ Opinions Related to Prescription Drugs Rachel F. Harbut and Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics offers guidance on stewardship and professionalism. AMA J Ethics. 2019;21(8):E642-644. doi: 10.1001/amajethics.2019.642. Pagination First page « First Previous page ‹ Previous … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page Next › Last page Last »
Case and Commentary Apr 2019 Should a Psychiatrist Prescribe a Nanodrug to Help Parents Monitor a Teen’s Adherence? Constance E. George, MD, MA Ethical stakes include a psychiatrist’s care management responsibilities and burdens borne by family members over the course of the patient’s care. AMA J Ethics. 2019;21(4):E317-323. doi: 10.1001/amajethics.2019.317.
Medicine and Society May 2019 How Should Mechanical Circulatory Support Be Deactivated for Patients With Depression at the End of Life? Stephan R. Weinland, PhD, MS and James Levenson, MD End-stage heart failure patients can experience depression along with their chronic illness. Multidisciplinary responses are critical. AMA J Ethics. 2019;21(5):E429-434. doi: 10.1001/amajethics.2019.429.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Policy Forum Nov 2019 Why Quality-of-Life Data Collection and Use Should Be Standardized When Evaluating Candidates for Hand Transplantation Martin Kumnig, PhD, MSc, Emma K. Massey, PhD, and Lisa S. Parker, PhD Improving candidate evaluation and informed consent is key to motivating authenticity, not just voluntariness. AMA J Ethics. 2019;21(11):E974-979. doi: 10.1001/amajethics.2019.974.
Case and Commentary Sep 2017 What Does Health Justice Look Like for People Returning from Incarceration? Lisa Puglisi, MD, Joseph P. Calderon, CHW, and Emily A. Wang, MD, MAS Equitable transitions of care for incarcerated patients returning to the community will require physician advocacy and systems-level change. AMA J Ethics. 2017;19(9):903-910. doi: 10.1001/journalofethics.2017.19.9.ecas4-1709.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
Policy Forum Jul 2019 How Should Unaccompanied Minors in Immigration Detention Be Protected From Coercive Medical Practices? Giselle Malina Safeguards are urgently needed for assessments of what constitutes appropriate care for unaccompanied minors in US detention facilities. AMA J Ethics. 2019;21(7):E603-610. doi: 10.1001/amajethics.2019.603.
Health Law Jul 2019 Regional Unrepresented Patient Advocacy Committee as an Alternative for Decision Making Lisa K. Anderson-Shaw, DrPH, MA, MSN, ANP-BC A UPAC is an alternative to engaging a guardianship court appointment process or to using physicians or ethics committees as decision makers. AMA J Ethics. 2019;21(7):E594-599. doi: 10.1001/amajethics.2019.594.
Medicine and Society Jul 2019 Who Are “Unrepresented” Patients and What Count as “Important” Medical Decisions for Them? David Ozar, PhD A look at current literature and work by a statewide initiative can motivate development of policies that help respond to unrepresented patients’ needs. AMA J Ethics. 2019;21(7):E611-616. doi: 10.1001/amajethics.2019.611.
AMA Code Says Aug 2019 AMA Code of Medical Ethics’ Opinions Related to Prescription Drugs Rachel F. Harbut and Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics offers guidance on stewardship and professionalism. AMA J Ethics. 2019;21(8):E642-644. doi: 10.1001/amajethics.2019.642.